Globe Life (GL) Q4 2025 earnings summary

Executive summary

• Net income for Q4 2025 was $266 million ($3.29/share), up from $255 million ($3.01/share) year-over-year; full-year net income was $1.16 billion ($14.07/share), up from $1.07 billion ($11.94/share).

• Net operating income for Q4 was $274 million ($3.39/share), up 8% year-over-year; full-year 2025 net operating income was $1.20 billion ($14.52/share), up from $1.11 billion ($12.37/share).

• Focuses on underserved lower- and middle-income markets, with a persistent in-force policy base of 17.2 million policies as of year-end 2025.

• Majority of pretax operating income is generated from stable underwriting margins, not impacted by interest rate or equity market fluctuations.

• Management team is highly experienced, with decades of relevant industry experience.

Financial highlights

• Premium income reached $4.89 billion in 2025, with a 5-year CAGR of 5.1%; Q4 total premium revenue grew 5% year-over-year.

• Life premium revenue increased 3% to $850 million in Q4; health premium revenue grew 9% to $392 million.

• Underwriting margins continued to grow, with life insurance margin at $1.51 billion and health insurance at $390 million in 2025.

• Net investment income for Q4 was $281 million (flat year-over-year); 2025 portfolio yield was 5.29%.

• Administrative expenses were $92 million for Q4, up 1% year-over-year, representing 7.4% of premium.

Outlook and guidance

• Net operating income per diluted share for 2026 is projected at $14.95–$15.65, representing 5% EPS growth at midpoint.

• Total premium revenue is expected to grow 7%-8% in 2026; life premium revenue 4%-4.5%, health premium revenue 14%-16%.

• Normalized EPS growth (excluding assumption updates) is projected at approximately 10%.

• Underwriting margins as a percent of premium are expected at 41.5%-44.5% for life and 23%-27% for health.

• Goal to surpass 28,000 exclusive agents and $1.4 billion in annual sales by 2030.